Rare diseases
Investigational molecules
Locations
Back to Portugal23 clinical trials in Viana Do Castelo, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)PortugalStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
PortugalStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
PortugalA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
PortugalA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
PortugalA Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
PortugalTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
PortugalStudy on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib
PortugalStudy on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis
PortugalStudy of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
PortugalStudy on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury
PortugalStudy on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome
PortugalThe busiest research cities in the country
What the registry says about research in the country
Investigating innovative treatments for various autoimmune conditions, including Primary Sjögren's Syndrome and Lupus Erythematosus. Research focuses on evaluating new therapeutic agents for managing systemic and cutaneous manifestations.
Studies aim to improve disease control and patient quality of life through targeted interventions.
Clinical research examining treatments for inflammatory bowel conditions and digestive disorders, including Crohn's Disease and Ulcerative Colitis. Studies evaluate long-term efficacy of novel therapeutic approaches.
Investigations focus on improving treatment outcomes and disease management strategies.
Comprehensive research into Non-alcoholic Steatohepatitis (NASH) and metabolic disorders, including Type 2 Diabetes. Studies evaluate innovative treatments and combination therapies.
Research aims to address both disease progression and symptom management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
